, Hong Kong

Public warned against this oral product

It may contain dangerous drug ingredient.

The Department of Health today urged people not to buy or consume Wei C Yin Qiao Pian, as it may contain dangerous drug ingredients.

The Hospital Authority informed the department that a 41-year-old woman was sent to Princess Margaret Hospital in October with rhabdomyolysis and hypokalemia. Her blood potassium level was found to be low.

She recently told her doctor she had consumed the product.

Laboratory tests on it found the presence of two undeclared and banned Western medicines, phenacetin and aminophenazone. However, the ingredients listed on the bottle, including vitamin C, paracetamol and chlorpheniramine maleate, were not detected.

The product was bought from the Mainland by the patient.

Phenacetin and aminophenazone were used previously as painkillers but were banned in Hong Kong due to their severe side effects.

People who have bought the product should stop using it immediately, and consult doctors if feeling unwell.

Join Hong Kong Business community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Top News

Hong Kong and Shanghai to enhance financial ties
The two cities will leverage on their competitive advantage to boost their financial cooperation.
HK Express load factors exceed 97% in April amidst Easter holidays
Current bookings to North Asian destinations exceed 90% occupancy as Golden Week approaches.
Aviation
PolyU partners with ZEISS for myopia control tech advancement
The partnership focuses on developing myopia control and other ophthalmic technologies.
Healthcare